United States Healthcare Equipment & Supplies

Neuropace Inc (NPCE)

Track

Neuropace Inc has seen no insider trading activity within the last three months. The most recent transactions occurred in December 2025, involving planned sales by Chief Medical Officer Martha Morrell. Prior to this period, various officers and major shareholders executed multiple divestments throughout 2024 and 2025.
Ticker: NPCE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Neuropace Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Morrell Martha CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
394.95
Quantity 93,761 +39.9%
Value US$3,253,586
MARTHA J MORRELL Officer Officer
Transaction date
Proposed sale
Price
307.96
Quantity 32,481
Value US$4,120,406
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
405.68
Quantity 9,718 -21.2%
Value US$1,388,355
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
15.83
Quantity 134,136 -3.9%
Value US$2,123,373
Morrell Martha CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
13.72
Quantity 78,334 -48.9%
Value US$1,074,844
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
9.40
Quantity 5,270,845 -100.0%
Value US$49,545,943
Morrell Martha CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
15.00
Quantity 200 -0.2%
Value US$3,000
MARTHA J MORRELL Officer Officer
Transaction date
Proposed sale
Price
14.69
Quantity 78,534
Value US$1,153,664
Morrell Martha CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
15.00
Quantity 100 -0.1%
Value US$1,500
MARTHA J MORRELL Officer Officer
Transaction date
Proposed sale
Price
14.13
Quantity 100
Value US$1,413
Morrell Martha CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
15.01
Quantity 3,200 -3.5%
Value US$48,032
MARTHA J MORRELL Officer Officer
Transaction date
Proposed sale
Price
14.02
Quantity 3,200
Value US$44,864
1.5
KCK LTD. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
5.45
Quantity 223,991
Value US$1,221,042
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
5.45
Quantity 223,991 -4.1%
Value US$1,221,042
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.02
Quantity 147 -0.0%
Value US$885
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.09
Quantity 4,082 -0.1%
Value US$24,853
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.10
Quantity 3,720 -0.1%
Value US$22,679
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.29
Quantity 4,878 -0.1%
Value US$30,692
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.28
Quantity 3,294 -0.1%
Value US$20,686
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.57
Quantity 6,900 -0.1%
Value US$45,336
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.50
Quantity 4,017 -0.1%
Value US$26,098
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.54
Quantity 4,031 -0.1%
Value US$26,360
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.35
Quantity 2,572 -0.0%
Value US$16,320
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.12
Quantity 2,504 -0.0%
Value US$15,317
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.10
Quantity 3,123 -0.1%
Value US$19,065
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.43
Quantity 6,000 -0.1%
Value US$38,552
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.66
Quantity 4,910 -0.1%
Value US$32,687
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.92
Quantity 5,757 -0.1%
Value US$39,830
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.97
Quantity 3,318 -0.1%
Value US$23,115
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.87
Quantity 3,843 -0.1%
Value US$26,401
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.77
Quantity 4,882 -0.1%
Value US$33,051
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.73
Quantity 4,749 -0.1%
Value US$31,961
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.63
Quantity 5,059 -0.1%
Value US$33,541
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.62
Quantity 5,821 -0.1%
Value US$38,535
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
6.60
Quantity 5,858 -0.1%
Value US$38,663
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
7.54
Quantity 282 -0.0%
Value US$2,126
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
7.50
Quantity 765 -0.0%
Value US$5,738
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
7.59
Quantity 1,993 -0.0%
Value US$15,127
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
7.50
Quantity 11 -0.0%
Value US$82
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
7.50
Quantity 14 -0.0%
Value US$105
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
7.60
Quantity 2,093 -0.0%
Value US$15,907
1.5
KCK LTD. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
7.76
Quantity 190,000
Value US$1,474,400
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
7.76
Quantity 4,314 -0.1%
Value US$33,477
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.03
Quantity 4,674 -0.1%
Value US$65,576
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.01
Quantity 8,842 -0.3%
Value US$123,876
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.02
Quantity 15,690 -0.5%
Value US$219,974
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.06
Quantity 1,781 -0.1%
Value US$25,041
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.29
Quantity 21,791 -0.6%
Value US$311,393
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.05
Quantity 24,609 -0.7%
Value US$345,756
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.02
Quantity 18,253 -0.5%
Value US$255,907
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.06
Quantity 2,623 -0.1%
Value US$36,879
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.15
Quantity 300 -0.0%
Value US$4,245
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.01
Quantity 14,069 -0.4%
Value US$197,107
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.42
Quantity 23,101 -0.7%
Value US$333,116
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
14.49
Quantity 461,899 -11.5%
Value US$6,692,917
Irina Ridley Chief Legal Officer Officer
Transaction date
Proposed sale
Price
13.63
Quantity 3,936
Value US$53,629
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.17
Quantity 3,446 -4.2%
Value US$52,278
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.07
Quantity 14,143 -14.8%
Value US$213,122
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.04
Quantity 663 -0.7%
Value US$9,971
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.08
Quantity 1,923 -2.0%
Value US$28,990
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.10
Quantity 11,262 -10.3%
Value US$170,004
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 1 -0.0%
Value US$15
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.03
Quantity 827 -0.8%
Value US$12,426
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.12
Quantity 13,300 -10.8%
Value US$134,648
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.00
Quantity 102 -0.1%
Value US$1,020
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.14
Quantity 2,730 -2.2%
Value US$27,695
Martha Morrell Chief Medical Officer Officer
Transaction date
Proposed sale
Price
9.99
Quantity 48,397
Value US$483,486
Morrell Martha Chief Medical Officer Officer
Transaction date
Planned sale
Price
8.16
Quantity 11,005 -8.0%
Value US$89,773
Martha Morrell Affiliate
Transaction date
Proposed sale
Price
8.16
Quantity 11,005
Value US$89,773
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
8.73
Quantity 3,241 -0.1%
Value US$28,294
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
8.84
Quantity 7,282 -0.1%
Value US$64,373
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
8.72
Quantity 5,644 -0.1%
Value US$49,216
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
8.75
Quantity 4,681 -0.1%
Value US$40,959
1.5
KCK Ltd. Shareholder
Transaction date
Proposed sale
Price
8.74
Quantity 262,836
Value US$2,297,187
1.5
KCK LTD. Large shareholder
Transaction date
Sale
Price
8.96
Quantity 6,490 -0.1%
Value US$58,150
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-04 2025-12-15 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
93,761 +39.9%
394.95
US$3,253,586 		93,761 +39.9% 394.95 US$3,253,586
2025-12-15 2025-12-15 PrS Proposed sale
MARTHA J MORRELL

Officer

Officer
32,481
307.96
US$4,120,406 		32,481 307.96 US$4,120,406
2025-05-16 2025-05-14 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
9,718 -21.2%
405.68
US$1,388,355 		9,718 -21.2% 405.68 US$1,388,355
2025-05-16 2025-05-14 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
134,136 -3.9%
15.83
US$2,123,373 		134,136 -3.9% 15.83 US$2,123,373
2025-02-25 2025-02-21 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
78,334 -48.9%
13.72
US$1,074,844 		78,334 -48.9% 13.72 US$1,074,844
2025-02-20 2025-02-20 S Sale
1.5
KCK LTD.
Large shareholder
5,270,845 -100.0%
9.40
US$49,545,943 		5,270,845 -100.0% 9.40 US$49,545,943
2025-01-31 2025-01-30 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
200 -0.2%
15.00
US$3,000 		200 -0.2% 15.00 US$3,000
2025-01-30 2025-01-30 PrS Proposed sale
MARTHA J MORRELL

Officer

Officer
78,534
14.69
US$1,153,664 		78,534 14.69 US$1,153,664
2025-01-31 2025-01-29 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
100 -0.1%
15.00
US$1,500 		100 -0.1% 15.00 US$1,500
2025-01-29 2025-01-29 PrS Proposed sale
MARTHA J MORRELL

Officer

Officer
100
14.13
US$1,413 		100 14.13 US$1,413
2025-01-28 2025-01-24 PlS Planned sale
Morrell Martha

CHIEF MEDICAL OFFICER

Officer
3,200 -3.5%
15.01
US$48,032 		3,200 -3.5% 15.01 US$48,032
2025-01-24 2025-01-24 PrS Proposed sale
MARTHA J MORRELL

Officer

Officer
3,200
14.02
US$44,864 		3,200 14.02 US$44,864
2024-10-28 2024-10-25 PrS Proposed sale
1.5
KCK LTD.

10% Stockholder

Large shareholder
223,991
5.45
US$1,221,042 		223,991 5.45 US$1,221,042
2024-10-28 2024-10-25 S Sale
1.5
KCK LTD.
Large shareholder
223,991 -4.1%
5.45
US$1,221,042 		223,991 -4.1% 5.45 US$1,221,042
2024-10-28 2024-10-23 S Sale
1.5
KCK LTD.
Large shareholder
147 -0.0%
6.02
US$885 		147 -0.0% 6.02 US$885
2024-10-24 2024-10-22 S Sale
1.5
KCK LTD.
Large shareholder
4,082 -0.1%
6.09
US$24,853 		4,082 -0.1% 6.09 US$24,853
2024-10-22 2024-10-21 S Sale
1.5
KCK LTD.
Large shareholder
3,720 -0.1%
6.10
US$22,679 		3,720 -0.1% 6.10 US$22,679
2024-10-22 2024-10-18 S Sale
1.5
KCK LTD.
Large shareholder
4,878 -0.1%
6.29
US$30,692 		4,878 -0.1% 6.29 US$30,692
2024-10-18 2024-10-17 S Sale
1.5
KCK LTD.
Large shareholder
3,294 -0.1%
6.28
US$20,686 		3,294 -0.1% 6.28 US$20,686
2024-10-18 2024-10-16 S Sale
1.5
KCK LTD.
Large shareholder
6,900 -0.1%
6.57
US$45,336 		6,900 -0.1% 6.57 US$45,336
2024-10-18 2024-10-15 S Sale
1.5
KCK LTD.
Large shareholder
4,017 -0.1%
6.50
US$26,098 		4,017 -0.1% 6.50 US$26,098
2024-10-18 2024-10-14 S Sale
1.5
KCK LTD.
Large shareholder
4,031 -0.1%
6.54
US$26,360 		4,031 -0.1% 6.54 US$26,360
2024-10-18 2024-10-11 S Sale
1.5
KCK LTD.
Large shareholder
2,572 -0.0%
6.35
US$16,320 		2,572 -0.0% 6.35 US$16,320
2024-10-18 2024-10-10 S Sale
1.5
KCK LTD.
Large shareholder
2,504 -0.0%
6.12
US$15,317 		2,504 -0.0% 6.12 US$15,317
2024-10-18 2024-10-09 S Sale
1.5
KCK LTD.
Large shareholder
3,123 -0.1%
6.10
US$19,065 		3,123 -0.1% 6.10 US$19,065
2024-10-18 2024-10-08 S Sale
1.5
KCK LTD.
Large shareholder
6,000 -0.1%
6.43
US$38,552 		6,000 -0.1% 6.43 US$38,552
2024-10-18 2024-10-07 S Sale
1.5
KCK LTD.
Large shareholder
4,910 -0.1%
6.66
US$32,687 		4,910 -0.1% 6.66 US$32,687
2024-10-18 2024-10-04 S Sale
1.5
KCK LTD.
Large shareholder
5,757 -0.1%
6.92
US$39,830 		5,757 -0.1% 6.92 US$39,830
2024-10-18 2024-10-03 S Sale
1.5
KCK LTD.
Large shareholder
3,318 -0.1%
6.97
US$23,115 		3,318 -0.1% 6.97 US$23,115
2024-10-03 2024-10-02 S Sale
1.5
KCK LTD.
Large shareholder
3,843 -0.1%
6.87
US$26,401 		3,843 -0.1% 6.87 US$26,401
2024-10-03 2024-10-01 S Sale
1.5
KCK LTD.
Large shareholder
4,882 -0.1%
6.77
US$33,051 		4,882 -0.1% 6.77 US$33,051
2024-10-03 2024-09-30 S Sale
1.5
KCK LTD.
Large shareholder
4,749 -0.1%
6.73
US$31,961 		4,749 -0.1% 6.73 US$31,961
2024-10-03 2024-09-27 S Sale
1.5
KCK LTD.
Large shareholder
5,059 -0.1%
6.63
US$33,541 		5,059 -0.1% 6.63 US$33,541
2024-10-03 2024-09-26 S Sale
1.5
KCK LTD.
Large shareholder
5,821 -0.1%
6.62
US$38,535 		5,821 -0.1% 6.62 US$38,535
2024-10-03 2024-09-25 S Sale
1.5
KCK LTD.
Large shareholder
5,858 -0.1%
6.60
US$38,663 		5,858 -0.1% 6.60 US$38,663
2024-10-03 2024-09-23 S Sale
1.5
KCK LTD.
Large shareholder
282 -0.0%
7.54
US$2,126 		282 -0.0% 7.54 US$2,126
2024-10-03 2024-09-20 S Sale
1.5
KCK LTD.
Large shareholder
765 -0.0%
7.50
US$5,738 		765 -0.0% 7.50 US$5,738
2024-10-03 2024-09-13 S Sale
1.5
KCK LTD.
Large shareholder
1,993 -0.0%
7.59
US$15,127 		1,993 -0.0% 7.59 US$15,127
2024-10-03 2024-09-06 S Sale
1.5
KCK LTD.
Large shareholder
11 -0.0%
7.50
US$82 		11 -0.0% 7.50 US$82
2024-10-03 2024-09-04 S Sale
1.5
KCK LTD.
Large shareholder
14 -0.0%
7.50
US$105 		14 -0.0% 7.50 US$105
2024-10-03 2024-09-03 S Sale
1.5
KCK LTD.
Large shareholder
2,093 -0.0%
7.60
US$15,907 		2,093 -0.0% 7.60 US$15,907
2024-10-03 2024-08-30 PrS Proposed sale
1.5
KCK LTD.

10% Stockholder

Large shareholder
190,000
7.76
US$1,474,400 		190,000 7.76 US$1,474,400
2024-10-03 2024-08-30 S Sale
1.5
KCK LTD.
Large shareholder
4,314 -0.1%
7.76
US$33,477 		4,314 -0.1% 7.76 US$33,477
2024-05-03 2024-05-03 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
4,674 -0.1%
14.03
US$65,576 		4,674 -0.1% 14.03 US$65,576
2024-05-03 2024-05-02 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
8,842 -0.3%
14.01
US$123,876 		8,842 -0.3% 14.01 US$123,876
2024-05-03 2024-05-01 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
15,690 -0.5%
14.02
US$219,974 		15,690 -0.5% 14.02 US$219,974
2024-04-26 2024-04-24 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
1,781 -0.1%
14.06
US$25,041 		1,781 -0.1% 14.06 US$25,041
2024-04-23 2024-04-23 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
21,791 -0.6%
14.29
US$311,393 		21,791 -0.6% 14.29 US$311,393
2024-04-23 2024-04-22 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
24,609 -0.7%
14.05
US$345,756 		24,609 -0.7% 14.05 US$345,756
2024-04-23 2024-04-19 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
18,253 -0.5%
14.02
US$255,907 		18,253 -0.5% 14.02 US$255,907
2024-04-18 2024-04-18 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
2,623 -0.1%
14.06
US$36,879 		2,623 -0.1% 14.06 US$36,879
2024-04-18 2024-04-17 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
300 -0.0%
14.15
US$4,245 		300 -0.0% 14.15 US$4,245
2024-04-18 2024-04-16 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
14,069 -0.4%
14.01
US$197,107 		14,069 -0.4% 14.01 US$197,107
2024-04-15 2024-04-12 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
23,101 -0.7%
14.42
US$333,116 		23,101 -0.7% 14.42 US$333,116
2024-04-15 2024-04-11 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
461,899 -11.5%
14.49
US$6,692,917 		461,899 -11.5% 14.49 US$6,692,917
2024-03-15 2024-03-15 PrS Proposed sale
Irina Ridley

Chief Legal Officer

Officer
3,936
13.63
US$53,629 		3,936 13.63 US$53,629
2024-02-06 2024-02-05 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
3,446 -4.2%
15.17
US$52,278 		3,446 -4.2% 15.17 US$52,278
2024-02-06 2024-02-02 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
14,143 -14.8%
15.07
US$213,122 		14,143 -14.8% 15.07 US$213,122
2024-02-01 2024-02-01 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
663 -0.7%
15.04
US$9,971 		663 -0.7% 15.04 US$9,971
2024-02-01 2024-01-31 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
1,923 -2.0%
15.08
US$28,990 		1,923 -2.0% 15.08 US$28,990
2024-02-01 2024-01-30 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
11,262 -10.3%
15.10
US$170,004 		11,262 -10.3% 15.10 US$170,004
2024-01-26 2024-01-25 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
1 -0.0%
15.00
US$15 		1 -0.0% 15.00 US$15
2024-01-26 2024-01-24 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
827 -0.8%
15.03
US$12,426 		827 -0.8% 15.03 US$12,426
2023-12-28 2023-12-27 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
13,300 -10.8%
10.12
US$134,648 		13,300 -10.8% 10.12 US$134,648
2023-12-28 2023-12-26 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
102 -0.1%
10.00
US$1,020 		102 -0.1% 10.00 US$1,020
2023-12-22 2023-12-20 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
2,730 -2.2%
10.14
US$27,695 		2,730 -2.2% 10.14 US$27,695
2023-12-20 2023-12-20 PrS Proposed sale
Martha Morrell

Chief Medical Officer

Officer
48,397
9.99
US$483,486 		48,397 9.99 US$483,486
2023-12-07 2023-12-06 PlS Planned sale
Morrell Martha

Chief Medical Officer

Officer
11,005 -8.0%
8.16
US$89,773 		11,005 -8.0% 8.16 US$89,773
2023-12-06 2023-12-06 PrS Proposed sale
Martha Morrell

Affiliate
11,005
8.16
US$89,773 		11,005 8.16 US$89,773
2023-12-01 2023-12-01 S Sale
1.5
KCK LTD.
Large shareholder
3,241 -0.1%
8.73
US$28,294 		3,241 -0.1% 8.73 US$28,294
2023-12-01 2023-11-30 S Sale
1.5
KCK LTD.
Large shareholder
7,282 -0.1%
8.84
US$64,373 		7,282 -0.1% 8.84 US$64,373
2023-12-01 2023-11-29 S Sale
1.5
KCK LTD.
Large shareholder
5,644 -0.1%
8.72
US$49,216 		5,644 -0.1% 8.72 US$49,216
2023-11-29 2023-11-28 S Sale
1.5
KCK LTD.
Large shareholder
4,681 -0.1%
8.75
US$40,959 		4,681 -0.1% 8.75 US$40,959
2023-11-29 2023-11-27 PrS Proposed sale
1.5
KCK Ltd.

Shareholder
262,836
8.74
US$2,297,187 		262,836 8.74 US$2,297,187
2023-11-29 2023-11-27 S Sale
1.5
KCK LTD.
Large shareholder
6,490 -0.1%
8.96
US$58,150 		6,490 -0.1% 8.96 US$58,150
Explore more

More insider trading research around Neuropace Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America